PULSATILE BIOACTIVE LUTEINIZING-HORMONE SECRETION IN MEN WITH CHRONIC-RENAL-FAILURE AND FOLLOWING RENAL-TRANSPLANTATION

被引:25
作者
TALBOT, JA
RODGER, RS
ROBERTSON, WR
机构
[1] UNIV MANCHESTER,HOPE HOSP,DEPT MED CLIN BIOCHEM,CLIN SCI BLDG,SALFORD M6 8HD,LANCS,ENGLAND
[2] WESTERN INFIRM & ASSOCIATED HOSP,DEPT GEN MED,GLASGOW G11 6NT,SCOTLAND
[3] STOBHILL GEN HOSP,GLASGOW G21 3UW,SCOTLAND
来源
NEPHRON | 1990年 / 56卷 / 01期
关键词
D O I
10.1159/000186103
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:66 / 72
页数:7
相关论文
共 29 条
[21]  
STONE WJ, 1985, 67TH ANN M END SOC, P141
[22]   THE PULSATILE SECRETION OF BIOACTIVE LUTEINIZING-HORMONE IN NORMAL ADULT MEN [J].
TALBOT, JA ;
STUART, R ;
RODGER, C ;
SHALET, SM ;
LITTLEY, MD ;
ROBERTSON, WR .
ACTA ENDOCRINOLOGICA, 1990, 122 (05) :643-650
[23]  
TALBOT JA, 1989, J ENDOCRINOL S, V121
[24]   QUANTITATIVE AND QUALITATIVE CHANGES IN LH-SECRETION FOLLOWING PULSATILE GNRH THERAPY IN A MAN WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM [J].
TSATSOULIS, A ;
SHALET, SM ;
TALBOT, A ;
ROBERTSON, WR .
CLINICAL ENDOCRINOLOGY, 1989, 30 (02) :167-175
[25]   THE PITUITARY LEYDIG-CELL AXIS IN MEN WITH SEVERE DAMAGE TO THE GERMINAL EPITHELIUM [J].
TSATSOULIS, A ;
WHITEHEAD, E ;
STJOHN, J ;
SHALET, SM ;
ROBERTSON, WR .
CLINICAL ENDOCRINOLOGY, 1987, 27 (06) :683-689
[26]   IMPROVED INVITRO BIOASSAY METHOD FOR MEASURING LUTEINIZING-HORMONE (LH) ACTIVITY USING MOUSE LEYDIG CELL PREPARATIONS [J].
VANDAMME, MP ;
ROBERTSON, DM ;
DICZFALUSY, E .
ACTA ENDOCRINOLOGICA, 1974, 77 (04) :655-671
[27]   PREFERENTIAL RELEASE OF BIOACTIVE LUTEINIZING-HORMONE IN RESPONSE TO ENDOGENOUS AND LOW-DOSE EXOGENOUS GONADOTROPIN-RELEASING-HORMONE PULSES IN MAN [J].
VELDHUIS, JD ;
JOHNSON, ML ;
DUFAU, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06) :1275-1282
[28]   PULSATILITY OF LUTEINIZING-HORMONE IN MEN WITH CHRONIC-RENAL-FAILURE - ABNORMAL RATHER THAN ABSENT [J].
WHEATLEY, T ;
CLARK, PMS ;
CLARK, JDA ;
RAGGATT, PR ;
EVANS, DB ;
HOLDER, R .
BRITISH MEDICAL JOURNAL, 1987, 294 (6570) :482-482
[29]  
1969, WHO TECHNICAL REPORT, V413